Adaptations in cholinergic transmission in the ventral tegmental area associated with the affective signs of nicotine withdrawal in rats

被引：46

作者：

Bruijnzeel, AW ^{[1
]}

Markou, A ^{[1
]}

机构：

[1] Scripps Res Inst, Dept Neuropharmacol, La Jolla, CA 92037 USA

来源：

NEUROPHARMACOLOGY | 2004年 / 47卷 / 04期

关键词：

nicotine; withdrawal; intracranial self-stimulation; antagonist; ventral tegmental area; rats;

D O I：

10.1016/j.neuropharm.2004.05.005

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

Chronic administration of nicotine induces adaptations in the brain reward circuit to counteract the acute drug effects; when nicotine administration ceases, these adaptations remain unopposed and lead to drug withdrawal. The present studies were conducted to assess the effects of chronic nicotine administration on nicotinic acetylcholine receptor (nAChR) activity in the ventral tegmental area (VTA) and the nucleus accumbens (Nacc) shell. A discrete-trial intracranial self-stimulation procedure that provides current-intensity thresholds as measures of brain reward function was used in rats. Previous studies have shown that withdrawal from nicotine-induced elevations in brain reward thresholds that are indicative of a decrease in brain reward function. We show here that injections of the nAChR antagonist dihydro-beta-erythroidine (DH E; 0.6-20 mug total bilateral dose) into the VTA, but not outside the VTA, resulted in significant elevations in brain reward thresholds in nicotine dependent rats (9 mg/kg/day nicotine hydrogen tartrate) while having no effect in saline-treated controls. By contrast, DHPE (0.6-20 mug total bilateral dose) injected into the Nacc shell had no effect on brain reward thresholds of nicotine- or saline-treated rats. The adaptations in cholinergic transmission in the VTA are likely to mediate, at least partly, the affective signs of nicotine withdrawal in humans. (C) 2004 Elsevier Ltd. All rights reserved.

引用

页码：572 / 579

页数：8

共 36 条

[1] Nornicotine is self-administered intravenously by rats [J].

Bardo, MT ;

Green, TA ;

Crooks, PA ;

Dwoskin, LP .

PSYCHOPHARMACOLOGY, 1999, 146 (03) :290-296

[2] SELF-ADMINISTERED NICOTINE ACTIVATES THE MESOLIMBIC DOPAMINE SYSTEM THROUGH THE VENTRAL TEGMENTAL AREA [J].

CORRIGALL, WA ;

COEN, KM ;

ADAMSON, KL .

BRAIN RESEARCH, 1994, 653 (1-2) :278-284

[3] NICOTINE MAINTAINS ROBUST SELF-ADMINISTRATION IN RATS ON A LIMITED-ACCESS SCHEDULE [J].

CORRIGALL, WA ;

COEN, KM .

PSYCHOPHARMACOLOGY, 1989, 99 (04) :473-478

[4] Bupropion enhances brain reward function and reverses the affective and somatic aspects of nicotine withdrawal in the rat [J].

Cryan, JF ;

Bruijnzeel, AW ;

Skjei, KL ;

Markou, A .

PSYCHOPHARMACOLOGY, 2003, 168 (03) :347-358

[5] Molecular and cellular aspects of nicotine abuse [J].

Dani, JA ;

Heinemann, S .

NEURON, 1996, 16 (05) :905-908

[6]

DICHIARA G, 1988, P NATL ACAD SCI USA, V85, P5274

[7] Nicotine self-administration in rats on a progressive ratio schedule of reinforcement [J].

Donny, EC ;

Caggiula, AR ;

Mielke, MM ;

Booth, S ;

Gharib, MA ;

Hoffman, A ;

Maldovan, V ;

Shupenko, C ;

McCallum, SE .

PSYCHOPHARMACOLOGY, 1999, 147 (02) :135-142

[8] Dramatic decreases in brain reward function during nicotine withdrawal [J].

Epping-Jordan, MP ;

Watkins, SS ;

Koob, GF ;

Markou, A .

NATURE, 1998, 393 (6680) :76-79

[9] Fluoxetine combined with a serotonin-1A receptor antagonist reversed reward deficits observed during nicotine and amphetamine withdrawal in rats [J].

Harrison, AA ;

Liem, YTB ;

Markou, A .

NEUROPSYCHOPHARMACOLOGY, 2001, 25 (01) :55-71

[10] Reduced dopamine output in the nucleus accumbens but not in the medial prefrontal cortex in rats displaying a mecamylamine-precipitated nicotine withdrawal syndrome [J].

Hildebrand, BE ;

Nomikos, GG ;

Hertel, P ;

Schilström, B ;

Svensson, TH .

BRAIN RESEARCH, 1998, 779 (1-2) :214-225

← 1 2 3 4 →